SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,124,000 | +10.8% | 121,835 | -5.3% | 0.27% | +17.3% |
| Q2 2022 | $3,723,000 | -43.2% | 128,718 | -36.5% | 0.23% | -33.6% |
| Q1 2022 | $6,551,000 | +3.5% | 202,682 | -6.6% | 0.35% | +11.9% |
| Q4 2021 | $6,329,000 | -3.2% | 217,042 | -11.4% | 0.31% | -9.3% |
| Q3 2021 | $6,535,000 | -16.1% | 245,022 | -3.1% | 0.34% | -17.3% |
| Q2 2021 | $7,789,000 | +18.2% | 252,968 | +0.5% | 0.42% | +4.8% |
| Q1 2021 | $6,587,000 | – | 251,604 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |